The present invention relates to tobacco (Nicotiana spp.) and preparations thereof that have reduced concentrations of certain constituents.
Plants contain a myriad of compounds that have industrial, agricultural, and medical uses. Such compounds may often be obtained by extraction using a variety of methods. In addition, plant matter itself is often employed in a variety of industries, e.g., textiles, and the chemical content of the plant matter may be altered prior to use, for example, by extraction processes, chemical treatment, heat treatment, or biological treatment.
Several processes have been employed to extract compounds from plant matter. For example, extractions have employed aqueous based and organic solvents, gases, and supercritical fluids. The process employed determines the compounds that are removed from the plant matter and the compounds that are retained in association with the plant matter.
In addition, the various processes used for extraction may differ according to cost, equipment needs, hazardous nature of the chemicals, complexity of the extraction, and adverse affects on the plant matter. For example, supercritical extraction in the manufacture of a plant-based product may negatively impact the economic feasibility of commercialization because the process is complex and expensive and requires specialized equipment. Other extraction methods may have a lower cost and be less complex but lead to an unsatisfactory product, e.g., one that has a negatively impacted flavor, aroma, or quality. Other processes may also be difficult to employ on a scale suitable for mass production.
Thus, there is a need for a simple, scaleable, environmentally sound, and commercially viable process to reduce unwanted constituents in plant matter, such as tobacco, without otherwise substantially altering the attributes of the product.
The invention features methods of reducing the amount of constituents in tobacco, as well as the tobacco obtained by such methods. More specifically, such methods are performed on the tobacco itself rather than on aqueous tobacco extracts. These methods are capable of reducing constituents without significant reduction in tobacco attributes. For example, the methods of the invention may be used to reduce secondary alkaloids selectively compared to primary alkaloids.
Accordingly, the invention features a method of reducing an amount of a constituent, e.g., a secondary alkaloid or polycyclic aromatic hydrocarbon (PAH), in tobacco by providing a vessel containing tobacco comprising the constituent; contacting the tobacco with a subcritical fluid; and removing the subcritical fluid from the vessel, e.g., by venting to the atmosphere or a second vessel. Preferably, the methods of the invention selectively reduce the amount of the constituent relative to a primary alkaloid.
In another aspect, the invention features a method of reducing the amount of a constituent in tobacco by providing a plurality of valved vessels connected to form a system, wherein the plurality of vessels contains tobacco comprising the constituent; contacting tobacco in a first vessel with a subcritical fluid; removing the subcritical fluid from the first vessel; and directing subcritical fluid, e.g., that from the first vessel, to a second vessel, to additional vessels, or to a waste vessel (or vented to atmosphere) as desired. The method may further include the steps of isolating the first vessel (or any other) from the system; and removing the tobacco from the first vessel, wherein the tobacco has a reduced amount of the constituent. This further step may occur before, during, or after the subcritical fluid has been removed from the first vessel.
In various embodiments of the above aspects of the invention, the method may include the step of separating a constituent from the subcritical fluid. This separation from the subcritical fluid may include the step of flowing the subcritical fluid containing the constituent into a second vessel that may or may not contain a substance capable of extracting a given constituent from the subcritical fluid. Exemplary substances include solid citric acid, an aqueous solution of citric acid, activated carbon, and solid magnesium silicate. Upon exiting a vessel or entering a second vessel (e.g., a separator vessel), the pressure or temperature of the subcritical fluid may be changed. In certain embodiments, a decrease in pressure causes a precipitation of the dissolved constituents. In other embodiments, the method further includes recirculating the subcritical fluid, after separation of the constituent, to a vessel containing tobacco. During recirculation, any flavor or aroma compounds removed from the tobacco with a constituent may be re-deposited in the tobacco.
A variety of subcritical fluids, as disclosed herein, may be employed in the methods of the invention. The temperature and pressures employed for each subcritical fluid (or mixture thereof) may vary depending on the subcritical fluids employed. The subcritical fluid may be in liquid form, e.g., a compressed gas, or in gas form.
In various embodiments, the methods reduce the amount of a constituent, e.g., secondary alkaloids or PAHs, in the tobacco by at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 75%, 85%, or 95%.
In yet another embodiment, the methods selectively reduce the amount of a constituent, e.g., secondary alkaloids or PAHs, in the tobacco by at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 75%, 85%, or 95%. The methods preferably retain at least 30%, 40%, 50%, 75%, 85%, 95%, or 99% of a primary alkaloid or a particular attribute, such as flavor or aroma compounds.
The tobacco employed typically has a moisture content of between 5-60%, e.g., at least 10%, 15%, 20%, 30%, 40%, or 50%. The pH of the tobacco is typically between 4 and 9, e.g., at least pH 5, 6, 7, or 8.
The invention further features tobacco or a tobacco product treated by the above-described methods.
By a “chlorofluorocarbon” is meant a compound including only carbon, fluorine, and chlorine atoms.
By a “chlorofluorohydrocarbon” is meant a compound including only carbon, hydrogen, fluorine, and chlorine atoms.
By “constituent” is meant secondary alkaloids and polycyclic aromatic hydrocarbons (PAH) found in tobacco. By “PAHs” is meant anthracene, anthanthrene, benzo(a)pyrene, coronene, fluoranthene, fluorene, naphthalene, phenanthrene, pyrene, and perylene. By “secondary alkaloid” is meant N-nitrosodimethylamine, N-nitrosodiethylamine, N-nitrosopyrrolidine, N-nitrosodiethanolamine, N-nitrosonornicotine (NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), N-nitrosoanatabine (NAT), or N-nitrosoanabasine (NAB).
By “primary alkaloid” is meant any alkaloid other than a secondary alkaloid.
By “tobacco attribute” is meant a flavor or aroma compound.
By a “hydrocarbon” is meant a compound including only carbon and hydrogen atoms.
By “reducing” is meant a lowering the detectable amount of a constituent in tobacco.
By “subcritical fluid” is meant a compound, or mixture of compounds, that is a gas at ambient temperature and pressure. The term encompasses both the liquid and gaseous phases for such a compound. Exemplary subcritical fluids include, without limitation, carbon dioxide, chlorofluorocarbons, chlorofluorohydrocarbons (e.g., Freon 22), hydrocarbons (e.g., ethane, propane, and butane), nitrous oxide, and combinations thereof.
By “tobacco” is meant any part of any member of the genus Nicotiana, e.g., leaves and stems. The tobacco may be whole, shredded, cut, cured, fermented, or otherwise processed. Tobacco may also be in the form of finished products, including but not limited to smokeless tobacco, snuff (moist or dry), chewing tobacco, cigarettes, cigars, and pipe tobacco.
Laboratory scale and suitable industrial scale methods of selectively reducing the amount of certain constituents in tobacco are described along with test data detailing the effectiveness of such methods. Notably, these methods are performed on tobacco itself. In addition, the tobacco can be from any source, including dried, cured, or processed, and can further be in the form of finished products, e.g., cigarettes, snuff (moist or dry), and cigars. These methods can reduce the amount of one or more constituents without substantially removing tobacco attributes.
As shown in
As further shown in
The subcritical fluid, once depleted of any dissolved or suspended constituents may be recirculated to the vessel 6, as shown, via line R. Circulation pump 4 may be designed such that subcritical fluid entering its inlet from line R may, once again, be pressurized so as to liquify before entering vessel 6. Those having ordinary skill in the art will recognize that pump 4 may thus act to re-pressurize the subcritical fluid entering pump 4 from either supply vessel 1 or line R. Following completion of the reduction process, the system may be depressurized and constituent-reduced tobacco 5 removed. The process time may vary depending on a variety of processing parameters. One of ordinary skill in the art will readily be able to determine suitable process times. Ranges of appropriate process times are discussed below in connection with trial runs performed on a laboratory-scale system.
The virtually continuous circulation of subcritical fluid and the inherent capability of reducing constituents from multiple charges of tobacco residing in a plurality of vessels are two clear advantages to be exploited. Elimination of costly down time brought about by emptying and recharging of a single vessel 6 is achievable with use of several (typically three or four) valved vessels 6 operating in series. Vessels may also be operated in parallel. As noted above, subcritical fluid is pumped in series through the several vessels 6. When the charge of tobacco in one of the vessels has become constituent-reduced and is ready to be removed, the subcritical fluid can be diverted from that vessel to another vessel containing tobacco or a separation vessel. This subcritical fluid may still be effective for reducing constituents from other charges of tobacco in other vessels. The vessel from which tobacco is ready to be removed may be isolated from the system without interfering with on-going reductions in other vessels. New tobacco may then be placed into the vessel, and the process can continue without overall system interruption.
Preferably, treated tobacco substantially retains the taste and aroma of untreated tobacco. Alternatively, any flavor or aroma compounds removed during treatment may be re-deposited in the tobacco, e.g., after removal of any constituents from the subcritical fluid. The flavor and aroma content of tobacco can be determined by taste and smell tests.
The following examples illustrate various embodiments of the present invention and are not intended to be limiting in any way.
The carbon dioxide utilized according to the present invention should be a subcritical fluid (critical point 31° C. and 1070 psi), e.g., a liquid. In practicing the process of the present invention, carbon dioxide temperature, pressure, or both can be adjusted to ensure that it is a subcritical fluid, for example, by an inlet heat exchanger (not shown). The run pressure was held essentially constant (in the range of between about 1000 and 2200 psi) for a given run. Runs were performed at essentially constant temperatures ranging between about 0° C. and 24° C. Although a range of mass of subcritical fluid: mass of tobacco ratios can be used, typically between 21 to 50 grams of carbon dioxide per gram of tobacco were used to reduce the maximum amount of constituent.
Table 1 shows data on the reduction of constituents in tobacco employing the laboratory-scale system described above. As shown in Table 1, the process is selective for the reduction of secondary alkaloids relative to primary alkaloids.
Additional experiments according to the method of Example 1 were carried out using Freon 22 (chlorodifluoromethane) (critical point 96° C., 716 psi) instead of carbon dioxide. The data are shown in Table 2. Exemplary conditions for use of Freon 22 include 0 to 50° C., 100 to 2000 psi, and a mass of Freon 22 to mass of tobacco ratio of 20 to 100.
Additional experiments according to the method of Example 1 were carried out using propane (critical point 96.7° C., 617 psi) instead of carbon dioxide. The data are shown in Table 3. In general, the conditions for use of propane are 0 to 50° C., 100 to 2000 psi, and a mass of propane to a mass of tobacco ratio of 20 to 100.
Table 4 shows data from an experiment according to Example 1 on the reduction of PAHs in tobacco by treatment with subcritical propane.
The amount of constituents in tobacco may also be reduced using the methods of the invention by employing ethane (critical point 32.2° C., 708 psi) or nitrous oxide (critical point 36.5° C., 1046 psi). Exemplary conditions for use of ethane include 0 to 30° C., 500 to 2000 psi, and a mass of ethane to a mass of tobacco ratio of 20 to 100. Exemplary conditions for use of nitrous oxide include 0 to 35° C., 500 to 2000 psi, and a nitrous oxide to tobacco ratio of 20 to 100.
The description of the specific embodiments of the methods and tobacco obtained therefrom is presented for the purposes of illustration. It is not intended to be exhaustive nor to limit the scope of the invention to the specific forms described herein. Although the invention has been described with reference to several embodiments, it will be understood by one of ordinary skill in the art that various modifications can be made without departing from the spirit and the scope of the invention, as set forth in the claims.
Other embodiments are within the claims.
This application is a continuation application of U.S. Ser. No. 10/623,006, filed Jul. 18, 2003, which claims the benefit of U.S. Provisional Application No. 60/397,060, filed Jul. 18, 2002, both of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2128043 | Garner | Aug 1938 | A |
2227863 | Rhodes | Jan 1941 | A |
3126011 | Haden et al. | Mar 1964 | A |
3390685 | Von Bethmann et al. | Jul 1968 | A |
3577997 | Bindig | May 1971 | A |
4153063 | Roselius et al. | May 1979 | A |
4200113 | Schmidt | Apr 1980 | A |
4211243 | Ohno et al. | Jul 1980 | A |
4333483 | de la Burde et al. | Jun 1982 | A |
4506682 | Muller | Mar 1985 | A |
4561452 | Gährs | Dec 1985 | A |
4714617 | Gährs | Dec 1987 | A |
4727889 | Niven, Jr. et al. | Mar 1988 | A |
4805642 | Rainer | Feb 1989 | A |
4898188 | Niven, Jr. et al. | Feb 1990 | A |
4967771 | Fagg et al. | Nov 1990 | A |
5012827 | Beutler et al. | May 1991 | A |
5018540 | Grubbs et al. | May 1991 | A |
5076293 | Kramer | Dec 1991 | A |
5119835 | Heemann et al. | Jun 1992 | A |
5472612 | Maxwell | Dec 1995 | A |
5497792 | Prasad et al. | Mar 1996 | A |
5810020 | Northway et al. | Sep 1998 | A |
6048404 | White | Apr 2000 | A |
6209546 | Baehl et al. | Apr 2001 | B1 |
20040049059 | Mueller | Mar 2004 | A1 |
Number | Date | Country |
---|---|---|
1 298 096 | Jun 2001 | CN |
4416785 | Nov 1995 | DE |
0283257 | Sep 1988 | EP |
0280817 | Sep 1998 | EP |
0908185 | Apr 1999 | EP |
64-74962 | Mar 1989 | JP |
05329301 | Dec 1993 | JP |
08-23952 | Jan 1996 | JP |
2002-503965 | May 2002 | JP |
WO 9858555 | Dec 1998 | WO |
WO 0165954 | Sep 2001 | WO |
WO 0200040 | Jan 2002 | WO |
WO 0228209 | Apr 2002 | WO |
WO 0232420 | Apr 2002 | WO |
Entry |
---|
English translation of Notice of Reasons for Rejection from Japanese Patent Application No. 2004-523607. |
Extended European Search Report from European Patent Application No. 10013132.-2114, dated Apr. 20, 2011 (date of completion of search) and May 3, 2011 (date of mailing of report). |
Chortyk et al., “The Application of Solid Phase Extraction to the Analysis of Tobacco-Specific Nitrosamines,” J. Chromatog. Sci. 29:522-527, 1991. |
Prokopczyk et al., “Supercritical Fluid Extraction in the Determination of Tobacco-Specific N-Nitrosamines in Smokeless Tobacco,” Chem. Res. Toxicol. 5:336-340, 1992. |
Prokopczyk et al., “Improved Methodology for the Quantitative Assessment of Tobacco-Specific N-Nitrosamines in Tobacco by Supercritical Fluid Extraction,” J. Agric. Food Chem. 43:916-922, 1995. |
Song et al., “Supercritical Fluid Extraction and Gas Chromatography/Mass Spectrometry for the Analysis of Tobacco-Specific Nitrosamines in Cigarettes,” Anal. Chem. 71:1303-1308, 1999. |
Supplementary European Search Report for European Patent Application No. 03765770, completed Jun. 17, 2005, mailed Aug. 11, 2005. |
Communication in European Patent Application No. 03765770, mailed Jul. 15, 2009. |
English Translation of Reasons for Rejection in Japanese Patent Application No. 2004-523607. |
English Translation of Reasons for Rejection from Japanese Patent Application No. 2004-523607, mailed Oct. 26, 2009. |
Examiner's First Report for Australian Patent Application No. 2003261187, mailed Nov. 11, 2008. |
First Office Action in Chinese Patent Application No. 03817167.8, stamped Jun. 23, 2006 (English translation provided). |
Office Action in Korean Patent Application No. 10-2005-7000847, mailed Oct. 13, 2009 (English summary provided). |
Final Office Action issued in Korean Patent Application No. 10-2005-7000847, dated Jun. 9, 2010, including associate's Report of Action in English language. |
International Search Report for PCT/US03/22585, completed Nov. 2, 2003, mailed Dec. 9, 2003. |
International Preliminary Examination Report for PCT/US03/22585, completed Dec. 20, 2004. |
Written Opinion of the International Searching Authority for PCT/US03/22585, mailed Apr. 9, 2004. |
Number | Date | Country | |
---|---|---|---|
20110067715 A1 | Mar 2011 | US |
Number | Date | Country | |
---|---|---|---|
60397060 | Jul 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10623006 | Jul 2003 | US |
Child | 12882783 | US |